Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Louse-Borne Relapsing Fever Surfaces in Europe

By LabMedica International staff writers
Posted on 16 Aug 2015
Borrelia recurrentis, a causative agent of relapsing fever, has for many centuries caused infections of often epidemic proportions and currently the disease is primarily found in north-eastern Africa, but is rarely seen in Europe. More...


Since the infection is exclusively transmitted by body lice and humans are their only host, large scale outbreaks are only expected under circumstances conducive to louse infestation. Lice that feed on infected humans acquire the Borrelia organisms that then multiply in the gut of the louse. When an infected louse feeds on an uninfected human, the organism gains access when the victim crushes the louse or scratches the area where the louse is feeding. B. recurrentis infects the person via mucous membranes and then invades the bloodstream.

Medical microbiologist at the University Medical Center Groningen (The Netherlands) investigated young asylum seekers from Eritrea one who presented with a history of headache, dizziness, right upper quadrant pain, myalgia, and a temperature of 39.3 °C. Another patient resented with general malaise, headache, a temperature of 38.5 °C and cough and his blood tests showed elevated inflammatory parameters, leucocytes count was 12.7 × 109/L, C-reactive protein (CRP) level of 320 mg/L. Malaria was suspected.

Thick and thin blood films did not show malaria parasites and commercial malaria antigen tests were negative. Filamentous unidentified structures were reported in the thick film by the laboratory of the peripheral hospital and louse-borne relapsing fever was suspected. Borrelia recurrentis was confirmed by 16S rDNA polymerase chain reaction (PCR) and sequencing directly from blood. The body louse Pediculus humanus humanus was recovered from their clothing. The patients’ clinical deterioration was provoked by the ceftriaxone administration leading to a severe Jarisch–Herxheimer reaction, so treatment was switched to doxycycline intravenously to reduce the risk of relapse.

The authors concluded that because infections with B. recurrentis pose a significant health risk to other migrants, aid workers, and healthcare personnel and arguably to the general population, screening and delousing should be considered for arriving migrants already at ports of entry into the European Union. The patients may have acquired body lice before arriving in Europe, but transmission of infected lice between migrants after arrival in Europe cannot be ruled out and could pose an additional public health challenge. The study was published on July 30, 2015, in the journal Eurosurveillance.

Related Links:

University Medical Center Groningen



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.